Rodenticide anticoagulant toxicity in dogs — brodifacoum,...

Alright, let's talk anticoagulant rodenticide toxicity. This is one of the most common and critical toxicities we manage. My approach is always direct: identify the specific agent, quantify the dose, establish the timeline, and then execute a precise treatment and monitoring plan.

Anticoagulant Rodenticide Toxicity in Dogs

These compounds, including brodifacoum, bromadiolone (second-generation, long-acting) and chlorophacinone (first-generation, shorter-acting), deplete vitamin K-dependent clotting factors (II, VII, IX, X). Clinical signs of bleeding typically manifest 2-5 days post-ingestion due to the half-life of these factors, with Factor VII being the first to be depleted.

Decontamination: Emesis vs. Skip

The decision to induce emesis hinges entirely on the timeline of ingestion and the patient's clinical status.

If ingestion was observed within 2-4 hours:

* Emesis is indicated. If the patient is asymptomatic and stable, induce emesis using apomorphine at 0.03 mg/kg IV or conjunctival tablet.
* Follow with activated charcoal. After successful emesis, administer activated charcoal at 1-2 g/kg PO. A single dose is typically sufficient for anticoagulant rodenticides as they do not commonly undergo significant enterohepatic recirculation necessitating repeat doses, unless a massive ingestion or sustained-release product.
Contraindications: Do not* induce emesis if the patient is already symptomatic (e.g., bleeding, lethargic, obtunded, seizuring), has a compromised gag reflex, or is a brachycephalic breed with a high aspiration risk. In these cases, proceed directly to activated charcoal if safe, or stabilize first.

If ingestion was >4 hours ago, or the timeline is unknown:

* Skip emesis. At this point, most of the toxin will have moved beyond the stomach, rendering emesis ineffective and potentially increasing aspiration risk.
* Administer activated charcoal. If the patient is stable and asymptomatic, give activated charcoal at 1-2 g/kg PO. This can still help adsorb any remaining toxin in the GI tract.
If the patient is already bleeding: Do not* induce emesis or activated charcoal. Focus on stabilization, blood products (plasma, whole blood), and immediate Vitamin K1 therapy.

Vitamin K1 Dosing and Administration

The antidote is Vitamin K1 (phytonadione).

* Dose: 2.5-5 mg/kg/day PO divided BID with fatty meal.
Administration: It is crucial to administer Vitamin K1 with a fatty meal* to ensure proper absorption, as it is a fat-soluble vitamin. NEVER give Vitamin K1 intravenously due to the high risk of anaphylaxis. Subcutaneous administration is acceptable for the initial dose if the patient is actively vomiting, but switch to oral as soon as possible.

Duration of Treatment

The duration of Vitamin K1 therapy depends on the specific anticoagulant rodenticide ingested:

* First-Generation (e.g., Chlorophacinone, Diphacinone): These agents have a shorter half-life. Treatment with Vitamin K1 is typically for 14 days.
* Second-Generation (e.g., Brodifacoum, Bromadiolone, Difethialone): These are long-acting anticoagulants. Treatment with Vitamin K1 is typically for 30 days.

PT/PTT Monitoring Schedule

Monitoring prothrombin time (PT) is essential to confirm efficacy and determine when it is safe to discontinue therapy.

Baseline/Diagnostic: If the ingestion time is unknown, or if the patient is symptomatic, a baseline PT/PTT should be performed immediately.

Post-ingestion (if no signs): If decontamination was performed and the patient is asymptomatic, a PT should be rechecked 48-72 hours post-ingestion. This allows enough time for Factor VII to be depleted if a toxic dose was ingested, even before clinical bleeding would occur. If PT is prolonged, initiate Vitamin K1 therapy.

After discontinuing Vitamin K1: This is critical. After completing the prescribed 14 or 30 days of Vitamin K1, wait 48-72 hours after the last dose of Vitamin K1, then recheck the PT.

* If the PT is normal, therapy can be safely discontinued.
* If the PT is still prolonged, the toxin has not yet cleared, and Vitamin K1 therapy must be reinitiated and continued for another 7-14 days before rechecking the PT again. This cycle continues until the PT remains normal 48-72 hours after the last dose.

The goal is to prevent bleeding and ensure the toxin is fully eliminated from the system before discontinuing the antidote. Always emphasize to owners the importance of the recheck PT, as stopping treatment prematurely is a common cause of relapse.